Taking everything into account, BMGL scores 2 out of 10 in our fundamental rating. BMGL was compared to 102 industry peers in the Health Care Providers & Services industry. BMGL has a bad profitability rating. Also its financial health evaluation is rather negative. BMGL has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

BMGL had negative earnings in the past year.
BMGL had a negative operating cash flow in the past year.

1.2 Ratios

BMGL has a worse Return On Assets (-73.60%) than 89.22% of its industry peers.
BMGL has a worse Return On Equity (-255.19%) than 78.43% of its industry peers.
BMGL has a better Return On Invested Capital (10.26%) than 80.39% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BMGL is significantly above the industry average of 9.16%.
The last Return On Invested Capital (10.26%) for BMGL is well below the 3 year average (22.16%), which needs to be investigated, but indicates that BMGL had better years and this may not be a problem.

		Industry Rank	Sector Rank
ROA	-73.6%
ROE	-255.19%
ROIC	10.26%

ROA(3y)-15.8%

ROA(5y)N/A

ROE(3y)-62.92%

ROE(5y)N/A

ROIC(3y)22.16%

ROIC(5y)N/A

1.3 Margins

BMGL's Operating Margin of 4.53% is fine compared to the rest of the industry. BMGL outperforms 62.75% of its industry peers.
BMGL's Operating Margin has declined in the last couple of years.
BMGL does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	4.53%
PM (TTM)	N/A
GM	N/A

OM growth 3Y-61.23%

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BMGL is creating value.
BMGL has more shares outstanding than it did 1 year ago.
The debt/assets ratio for BMGL has been reduced compared to a year ago.

2.2 Solvency

BMGL has an Altman-Z score of -0.26. This is a bad value and indicates that BMGL is not financially healthy and even has some risk of bankruptcy.
BMGL's Altman-Z score of -0.26 is on the low side compared to the rest of the industry. BMGL is outperformed by 79.41% of its industry peers.
BMGL has a Debt/Equity ratio of 0.28. This is a healthy value indicating a solid balance between debt and equity.
BMGL has a better Debt to Equity ratio (0.28) than 67.65% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.28
Debt/FCF	N/A
Altman-Z	-0.26

ROIC/WACC0.93

WACC11.05%

2.3 Liquidity

BMGL has a Current Ratio of 1.23. This is a normal value and indicates that BMGL is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of BMGL (1.23) is comparable to the rest of the industry.
BMGL has a Quick Ratio of 1.19. This is a normal value and indicates that BMGL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.19, BMGL is in line with its industry, outperforming 48.04% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.23
Quick Ratio	1.19

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

BMGL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -458.69%.
The Revenue has grown by 8.02% in the past year. This is quite good.
BMGL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.03% yearly.

EPS 1Y (TTM)-458.69%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-673.02%

Revenue 1Y (TTM)8.02%

Revenue growth 3Y2.03%

Revenue growth 5YN/A

Sales Q2Q%12.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BMGL. In the last year negative earnings were reported.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

BMGL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BMGL is cheaper than 99.02% of the companies in the same industry.